Betz A L, Gilboe D D, Drewes L R
Am J Physiol. 1975 Mar;228(3):895-900. doi: 10.1152/ajplegacy.1975.228.3.895.
The rate of unidirectional uptake, v, of L-[4,5-3H]leucine was studied in 17 isolated dog brains by means of an indicator-dilution technique using 22Na as the intravascular reference. The arterial leucine concentration was varied in increments by adding unlabeled leucine to the blood and v was determined after each change. The valine and isoleucine concentrations were varied independently to permit evaluation of their effect on leucine transport. A preliminary analysis indicated that both valine and isoleucine are competitive inhibitors. Therefore, all data were fitted to an equation that describes Michaelis-Menten kinetics in the presence of two competitive inhibitors. These calculations yielded an apparent Km for leucine transport of 1.58 mM plus or minus .28 SE, a V max of 0.323 mumol/g per min plus or minus .035 SE, and an apparent K i for inhibition of leucine transport of 1.76 mM plus or minus .34 SE for valine and 0.73 mM plus or minus .14 SE for isoleucine. In four isolated brains perfused with blood having a constant leucine level, indicator-dilution injections were made before, and at 1, 5, and 10 min after the start of perfusion with anoxic blood. These findings showed that, unlike glucose transport (Brain Res. 67: 307-316, 1974), the rate of lucine transport is unaffected by 10 min of anoxia.
采用以22Na作为血管内参考物的示踪剂稀释技术,在17个离体犬脑上研究了L-[4,5-3H]亮氨酸的单向摄取速率v。通过向血液中添加未标记的亮氨酸来逐步改变动脉亮氨酸浓度,并在每次改变后测定v。分别改变缬氨酸和异亮氨酸的浓度,以评估它们对亮氨酸转运的影响。初步分析表明,缬氨酸和异亮氨酸均为竞争性抑制剂。因此,所有数据均拟合到一个描述在两种竞争性抑制剂存在下的米氏动力学的方程。这些计算得出亮氨酸转运的表观Km为1.58 mM±0.28 SE,Vmax为0.323 μmol/g每分钟±0.035 SE,缬氨酸对亮氨酸转运抑制的表观Ki为1.76 mM±0.34 SE,异亮氨酸的为0.73 mM±0.14 SE。在4个用亮氨酸水平恒定的血液灌注的离体脑上,在开始用缺氧血液灌注前以及灌注后1、5和10分钟进行示踪剂稀释注射。这些结果表明,与葡萄糖转运不同(《脑研究》67: 307 - 316, 1974),亮氨酸转运速率不受10分钟缺氧的影响。